WAFA Therapeutics Iboga Bark Powder micro-dosing System

​

The WAFA System is designed with the intention to give users of WAFA Iboga Bark micro-dosing a reference standard in which to help guide their use of Iboga micro-dosing. By using our om-line planning guides, screening tests, personal diary and progress reports to help you adjust your micro-dosing plan your program and keep track of your progress and goals.

​

These standards are not Scientifically Calculated through long years of clinical trials with a non-changing compound.  iboga Bark Powder taken from the Iboga Tabernathe tree root is a natural substance and the quality and composition is unevenly distributed, just as in nature.

​

We at WAFA Therapeutics do not make any claims of specific knowledge or insight into the science of micro-dosing Iboga. There is none. There is however a great deal of scientific research and clinical trials using Ibogaine HCL, the main alkaloid in Iboga bark.

​

There is an extremely long historical record of the "safe" use of iboga as a personal and culturally accepted practice. The use of iboga in Bwiti religious ceremonies is believed to have started at least several hundred years ago, although the exact origins are difficult to pinpoint.

... In West Central Africa, "iboga" or "eboka" has traditionally been used by the indigenous Bwiti religion to conduct ceremonial rites. Eboka designates the root bark shavings of the Tabernanthe iboga plant, which is the major form used in rituals in Africa (Antonio et al., 2013;Fernandez & Fernandez, 2001). In the literature, the use of iboga plant material is referenced commonly by its ethnobotanical abbreviation T. iboga, whereas ibogaine refers to the indole alkaloid form (Alper, 2001). ...

​

What WAFA iboga micro-dosing System does is provide the safest and most effect direction for those wish to utilizes micro-dosing of iboga bark powder to facilitate gradual and sustained improvements in physical, emotional, and mental health.

 

System Components

1. Preparation and Dosage

   • Quality Assurance: We Source high-purity iboga bark directly from the local tribes in Camoroun Africa and process the bark into iboga Powder in our business in Spain.  Where it is inspected for contaminants and tested for a consistent potency.

   • ​

   • Initial Dosage: Start with a minimal dose (typically between 50-100 mg), gauging individual tolerance and adjusting accordingly to optimize therapeutic effects without overwhelming the body.

• Administration Schedule

  • Dosing Frequency: Micro-doses are administered every three days to prevent tolerance buildup and allow for cumulative benefits.

  • Treatment Duration: The treatment extends over a period, generally between several weeks to two months, followed by an evaluation period to assess benefits and determine further need.

• Monitoring and Adjustment

  • Ongoing Support: Incorporate 24-hour live support to provide assistance and address concerns as they arise during the treatment.

  • Adaptation of Doses: Adjust dosages based on feedback from continuous monitoring of physical and psychological responses, ensuring personalized treatment.

• Safety Protocols

  • Health Screening: Conduct an initial health screening focusing on both physical and psychological health to ensure suitability for micro-dosing.

  • Regular Check-ins: Establish scheduled check-ins with medical professionals to oversee progress and manage any potential risks.

• Goals and Outcomes

  • Immediate Goals: Reduce symptoms of anxiety, depression, and substance cravings, while enhancing mood, focus, and energy levels.

  • Long-Term Outcomes: Foster significant, long-lasting changes in lifestyle and behavior, promoting overall well-being and quality of life.

• Integration and Continuity

  • Lifestyle Integration: Encourage integration of insights and improvements gained from micro-dosing into daily life practices and decision-making.

  • Continuity of Care: Provide guidelines for maintaining or adapting micro-dosing practices post-treatment based on individual needs and long-term goals.

• System Goals

• The primary goal of the WAFA System is to empower individuals to proactively address and manage life’s challenges using iboga bark powder, enhancing their capacity to lead healthier, more fulfilled lives. This is achieved through a structured yet flexible regimen that respects each individual’s unique physiological and psychological makeup.

• Unique Attributes

• Home-Based Approach: Allows for a comfortable and personalized treatment environment.

• Holistic Support: Combines the therapeutic potential of iboga with comprehensive safety measures and professional guidance.

• Tailored to Individual Needs: Adapts to the specific responses and evolving needs of the user, promoting optimal outcomes.